Building resilience needs to be central to treating drug-resistant tuberculosis. Cox, H. & Loveday, M. The Lancet Global Health, 9(4):e381–e382, Elsevier Ltd, apr, 2021.
Building resilience needs to be central to treating drug-resistant tuberculosis [link]Paper  doi  bibtex   
@article{Cox2021,
author = {Cox, Helen and Loveday, Marian},
doi = {10.1016/S2214-109X(21)00056-5},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Cox, Loveday - 2021 - Building resilience needs to be central to treating drug-resistant tuberculosis.pdf:pdf},
issn = {2214109X},
journal = {The Lancet Global Health},
keywords = {OA,commentary,fund{\_}not{\_}ack},
mendeley-tags = {OA,commentary,fund{\_}not{\_}ack},
month = {apr},
number = {4},
pages = {e381--e382},
publisher = {Elsevier Ltd},
title = {{Building resilience needs to be central to treating drug-resistant tuberculosis}},
url = {www.thelancet.com/lancetgh},
volume = {9},
year = {2021}
}

Downloads: 0